Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis

Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis

Abstract Objective To assess through systematic review and meta-analysis whether plasma exchange (PE) is associated with prognosis in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients. Methods A systematic search of PubMed, MEDLINE, Embase, and CENTRAL databases from in...

Full description

Bibliographic Details
Main Authors:	Yosuke Yamada, Makoto Harada, Yuuta Hara, Ryohei Iwabuchi, Koji Hashimoto, Shuhei Yamamoto, Yuji Kamijo
Format:	Article
Language:	English
Published:	BMC 2021-01-01
Series:	Arthritis Research & Therapy
Subjects:	Microscopic polyangiitis Churg-Strauss syndrome Granulomatosis with polyangiitis Plasma exchange Meta-analysis
Online Access:	https://doi.org/10.1186/s13075-021-02415-z

Similar Items

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
by: Durga Prasanna Misra, et al.
Published: (2019-01-01)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
by: Michele V. Quan, et al.
Published: (2018-11-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01)

POSSIBILITIES OF COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF PRIMARY PULMONARY VASCULITIS
by: I. A. Sokolina, et al.
Published: (2016-06-01)

Silent acute myocarditis in eosinophilic granulomatosis with polyangiitis
by: Raquel Miriam Ferreira, et al.
Published: (2018-10-01)

Arthritis as a clinical manifestation of antineutrophil cytoplasmic antibody-associated systemic vasculitis: diagnostic difficulties
by: T. V. Beketova, et al.
Published: (2018-06-01)

Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis
by: Jun Ishizaki, et al.
Published: (2017-09-01)

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
by: Faverio P, et al.
Published: (2018-12-01)

RUSSIAN EXPERIENCE WITH USING MONOCLONAL ANTIBODIES TO B-LYMPHOCYTES (RITUXIMAB) IN SYSTEMIC VASCULITIDES ASSOCIATED WITH NEUTROPHIL CYTOPLASMIC ANTIBODIES (PRELIMINARY RESULTS OF THE RUSSIAN REGISTER NORMA)
by: T. V. Beketova, et al.
Published: (2014-06-01)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
by: Arman F, et al.
Published: (2018-11-01)

A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes
by: Ulf Persson, et al.
Published: (2013-12-01)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
by: Thomas Hellmark, et al.
Published: (2019-03-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Peripheral neuropathy as initial manifestation of Churg-Strauss Syndrome
by: Antonio Villa, et al.
Published: (2020-03-01)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
by: Michele Iudici, et al.
Published: (2016-10-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Pulmonary vasculitis: diagnosis and treatment
by: E Kh Anaev, et al.
Published: (2018-03-01)

Eosinophilic granulomatosis with polyangiitis in comorbidpatient: is the immunological diagnostics always unambiguous
by: V. N. Marchenko, et al.
Published: (2020-04-01)

Induction Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement: The Nephrologist's Point of View
by: Maurizio Salvadori, et al.
Published: (2018-07-01)

A case of eosinophilic granulomatosis with polyangiitis showing multiple white lichen lesions on the airway mucosa
by: Yosuke Kimura, et al.
Published: (2021-01-01)

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides
by: Peter Lamprecht, et al.
Published: (2018-04-01)

Eosinophilic Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis
by: Hiroyuki Ito, et al.
Published: (2020-12-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis
by: Hee Jin Park, et al.
Published: (2019-06-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

International guidelines for the management ofANCA-associated systemic vasculitides
by: T. V. Beketova
Published: (2019-03-01)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
by: Ekbote Gayatri, et al.
Published: (2019-01-01)

Primary Vasculitis in Childhood: GPA and MPA in Childhood
by: Mehul P. Jariwala, et al.
Published: (2018-08-01)

Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology
by: Filippo Fagni, et al.
Published: (2021-02-01)

Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China
by: Suying Liu, et al.
Published: (2021-03-01)

ANCA Associated Mononeuritis Multiplex with Overlap in Vasculitic Syndromes
by: Ravi Anadure, et al.
Published: (2017-01-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
by: Yang Zheng, et al.
Published: (2019-01-01)

GRANULOMATOSIS WITH POLYANGIITIS, WHICH IS PATHOGENETICALLY ASSOCIATED WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES: CLINICAL FEATURES
by: Tatiana Valentinovna Beketova
Published: (2012-12-01)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
by: Robson JC, et al.
Published: (2018-01-01)

Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients
by: Jolanta Dadonienė, et al.
Published: (2017-07-01)

Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study
by: Alicia Rodriguez-Pla, et al.
Published: (2021-04-01)

February 2018 imaging case of the month
by: Gotway MB
Published: (2018-02-01)

Granulomatosis with polyangiitis
by: Zubayer Ahmad, et al.
Published: (2016-12-01)

Microscopic polyangiitis associated with antineutrophil cytoplasmic antibodies: Clinical features
by: T V Beketova
Published: (2015-05-01)